Advancing Equitable Access to Lenacapavir for PrEP (Africa Focus)

Tuesday19May

13:00 - 14:30 GMT

Virtual

The recent significant changes to global health funding have severely impacted HIV prevention services for those who need them most, in particular key populations (KPs). Already, some countries are seeing concerning trends in data suggesting a resurgence in new infections. At the same time, powerful new HIV prevention options are now a reality, though their promise is not set to be fully realized according to current planning.

This webinar will provide an overview of what is happening now in African countries to HIV prevention services for KPs, featuring tools and analyses produced by GBGMC, in partnership with Access Bridge to support advocacy and planning at country levels.

Speakers will include an array of experts on the global landscape, as well as country and community perspectives.

Featured Resources

Document

Policy Review Tool for WHO-Aligned HIV Prevention Service Delivery

This tool, developed by Global Back Gay Men Connected (GBGMC), supports national and subnational programme managers, technical advisors and peer review teams in systematically reviewing existing national HIV PrEP guidelines against the WHO 2025 recommendations on lenacapavir (LEN) for HIV prevention. The goal of this tool is to assess whether national guidelines are comprehensive, equitable…

Document

LEN Rollout Resources and Tools

The resources listed in this document, alongside insights drawn from the report Getting PrEP Rollout Right This Time, can support countries in the early stages of LEN planning. These tools are being disseminated as part of a coordinated effort between AVAC, CHAI, CIFF, the Global Fund, PEPFAR, PSI, Unitaid, Wits RHI, and WHO under the…

External Link

PrEP Drug Interaction Checker

This website, developed and maintained by the University of Liverpool, provides clear, trustworthy, and up-to-date information about how different PrEP options, including oral PrEP, cabotegravir, lenacapavir, and the dapivirine vaginal ring, can interact with other drugs.

Document

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

These materials, developed by Zambia’s Ministry of Health, can be used to train clinicians and mobilisers in delivery of PrEP methods, including injectable lenacapavir (LEN), cabotegravir (CAB), the dapivirine vaginal ring (DVR), the Dual Prevention Pill (DPP), and oral PrEP.

Document

Zambia Guidelines for Pre and Post-Exposure Prophylaxis for HIV Infection, 2025

These clinical guidelines, developed by Zambia’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR), as well as the Dual Prevention Pill and oral PrEP.

Document

HIV Prevention Ambassador Training Package and Toolkit

The HIV Prevention Ambassador Training Package and Toolkit was created to prepare potential and current PrEP users to be leaders – or “Ambassadors” – in the rollout of PrEP for HIV prevention in their communities. Through interactive activities, discussion, and action planning, the training prepares Ambassadors to share information with their peers about PrEP methods…

External Link

Early Experiences with Usage of Long-acting Injectable Cabotegravir among Adults in Rural Ugandan and Kenyan Communities: Qualitative research from the SEARCH “Dynamic Choice HIV Prevention” intervention trials

This article from Journal of the International AIDS Society describes the results of a qualitative study exploring experiences with injectable cabotegravir (CAB for PrEP) among adults participating in the SEARCH Dynamic Choice HIV Prevention (DCP) trial in rural Kenya and Uganda, which evaluated HIV prevention uptake through a structured, person-centred DCP model.

Document

PrEP Clinical Reporting Tools

This suite of clinical reporting forms, developed by South Africa’s National Department of Health, can be used for PrEP reporting, including injectable lenacapavir (LEN). The download folder includes forms for PrEP initiation, continuation, pregnancy outcome reporting, and seroconversion reporting.

External Link

Lenacapavir Training Videos

These videos, developed by South Africa’s National Department of Health, can be used to train providers offering injectable lenacapavir (LEN) for PrEP, and include modules on screening, initiation, counselling, follow-up, side effects, special considerations, and reporting.

Spreadsheet

Lenacapavir Implementation Planning Tool

This tool, developed by South Africa’s National Department of Health, can be used to develop action plans for facilities introducing injectable lenacapavir (LEN).